InsiderTrades

Form 4 for SIBN SI-BONE, Inc.

Accepted 2024-06-17 00:00:00 ET · period of report 2024-06-14 · accession 0001562180-24-005137 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-06-17 2024-06-14 SIBN FRANCIS LAURA CEO, Dir M - OptEx $4.38 +68.7K 512.8K +15% +$300.7K
DM 2024-06-17 2024-06-14 SIBN FRANCIS LAURA CEO, Dir M - OptEx $0.00 -68.7K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-06-14 M A 57,392 $4.32 502,890 D — — (F2) Includes 1,414 shares acquired under the SI-BONE, Inc. 2018 Employee Stock Purchase Plan on May 15, 2024. (F1) Reflects the transfer of shares from the Reporting Person to The David & Laura Francis Joint Rev Tr. (F3) Includes 335,545 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
2 Common Common Stock 2024-06-14 M A 11,277 $4.68 512,753 D — —
3 Derivative Stock Option (Right to Buy) 2024-06-14 M D 57,392 $0.00 0 D $4.32 · — to 2025-05-25 57,392 Common Stock (F6) The shares subject to the option vest in equal monthly installments over four years commencing on May 26, 2015, subject to Reporting Person's continued service through each relevant vesting date. The shares subject to this option may be exercised prior to vesting, subject to Issuer's right to repurchase.
4 Derivative Stock Option (Right to Buy) 2024-06-14 M D 11,277 $0.00 0 D $4.68 · — to 2027-03-01 11,277 Common Stock (F5) The shares subject to the option vest in equal monthly installments over four years commencing on December 12, 2017, subject to Reporting Person's continued service through each relevant vesting date. The shares subject to this option may be exercised prior to vesting, subject to Issuer's right to repurchase.